Showing 1661-1670 of 5603 results for "".
When Alopecia Areata Signals More than Hair Loss
https://reachmd.com/programs/dermconsult/alopecia-areata-more-than-hair-loss/49023/Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
https://reachmd.com/programs/project-oncology/mbc-biopsies-map-immune-response-her2-tri-blockade/49186/How I Treat IgA Nephropathy: Lessons From the Case Files
https://reachmd.com/programs/kdigo-conversations-nephrology/title-how-i-treat-iga-nephropathy-lessons-from-the-case-files/37117/Join Dr. Dana Rizk (University of Alabama at Birmingham) as she leads a thought-provoking discussion on applying the updated KDIGO guidelines for IgA nephropathy (IgAN) treatment. She is joined by 2 distinguished guests: Dr. Gaia Coppock (University of Pennsylvania School of Medicine) and Dr. AndreFirst-in-Human Trial of a Germline-Targeting HIV Env Trimer Vaccine
https://reachmd.com/programs/clinicians-roundtable/first-in-human-trial-of-a-germline-targeting-hiv-env-trimer-vaccine/32855/Prioritizing Health Equity in Pediatric Practice: Strategies for Meaningful Change
https://reachmd.com/programs/clinicians-roundtable/prioritizing-health-equity-in-pediatric-practice-strategies-for-meaningful-change/37130/Recognizing how inequities can significantly impact pediatric care outcomes is essential to improving access, trust, and long-term health. Dr. Shelina Ramnarine is joined by Dr. Yolanda Evans to discuss actionable strategies that can help us deliver more inclusive care, from social determinant screeEpicutis Lipid Serum, DefenAge 12-factor Lip Enhancer, DefenAge 12-factor Lip Enhancer, Lumenis triLift
https://reachmd.com/topics/practice-development/epicutis-lipid-serum-defenage-12-factor-lip-enhancer-defenage-12-factor-lip-enhancer-lumenis-trilift/35425/Featuring James Y. Wang, MD, MBA; Jessica Weiser, MD, FAAD; Lori Azstalos, MD, FAAD; and Manuel Lopez, MD FACSmCRPC Care: Predicting Response to Radium-223 Treatment with a PET Scan
https://reachmd.com/programs/project-oncology/mcrpc-care-predicting-response-to-radium-223-treatment-with-a-pet-scan/17798/Here’s how a PET scan may be able to predict which patients with bone metastases from castration-resistant prostate cancer may respond to radium-223.Study Shows Importance of Comprehensive Genomic Profiling for NSCLC
https://reachmd.com/programs/project-oncology/study-shows-importance-of-comprehensive-genomic-profiling-for-nsclc/15463/What do we need to know about comprehensive genomic profiling and CGP-directed therapies for NSCLC patients?Case Management Strategies for Patients with ADPKD – Part 1
https://reachmd.com/programs/cme/case-management-strategies-for-patients-with-adpkd-part-1/13879/This program is no longer availble for credit This Expert Exchange webcast is designed to help improve clinicians’ ability to apply pharmacologic and non-pharmacologic strategies in tExploring Fungi in Cancer-Type Tumors & Cancer Therapeutics
https://reachmd.com/programs/project-oncology/exploring-fungi-in-cancer-type-tumors-cancer-therapeutics/14615/How will emerging data on fungi in cancer-type tumors impact the development of cancer therapeutics?